🇺🇸 MOXIFLOXACIN in United States

18,532 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Off Label Use — 2,257 reports (12.18%)
  2. Dyspnoea — 2,084 reports (11.25%)
  3. Drug Ineffective — 1,993 reports (10.75%)
  4. Drug Hypersensitivity — 1,931 reports (10.42%)
  5. Pneumonia — 1,925 reports (10.39%)
  6. Asthma — 1,901 reports (10.26%)
  7. Vomiting — 1,768 reports (9.54%)
  8. Pain — 1,611 reports (8.69%)
  9. Rash — 1,539 reports (8.3%)
  10. Wheezing — 1,523 reports (8.22%)

Source database →

MOXIFLOXACIN in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is MOXIFLOXACIN approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for MOXIFLOXACIN in United States?

Marketing authorisation holder not available in our data.